USFDA recommendation to file full BLA for Covaxin could be a setback for Bharat Biotech, Ocugen – Moneycontrol

A new clinical trial would mean a stretch of timelines, and possibly delay by several months. The USFDA can take about six to 10 months to approve a Biologic Licensing Application. Read More